Neuromuscular Diseases: Clinical Trials

9,905 trials for Neuromuscular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5086 completed, 1401 unknown, 1398 recruiting, 589 terminated. 3746 Not applicable, 1710 Phase 2, 970 Phase 3, 902 Phase 1, 434 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3746Completed 1967, Unknown 591, Recruiting 526, Not yet recruiting 244, Terminated 140, Active not recruiting 111, Withdrawn 97, Enrolling by invitation 53, Suspended 17
Phase 21710Completed 904, Terminated 219, Recruiting 183, Unknown 154, Active not recruiting 95, Withdrawn 68, Not yet recruiting 62, Enrolling by invitation 18, Suspended 7
Phase 3970Completed 588, Terminated 98, Unknown 97, Recruiting 86, Active not recruiting 43, Withdrawn 27, Not yet recruiting 21, Enrolling by invitation 10
Phase 1902Completed 443, Recruiting 151, Unknown 80, Terminated 74, Active not recruiting 56, Not yet recruiting 46, Withdrawn 32, Enrolling by invitation 15, Suspended 5
Phase 4434Completed 270, Unknown 57, Recruiting 31, Terminated 30, Not yet recruiting 16, Withdrawn 14, Active not recruiting 12, Enrolling by invitation 4
Early Phase 1123Completed 37, Recruiting 27, Unknown 18, Not yet recruiting 14, Withdrawn 8, Active not recruiting 7, Terminated 7, Suspended 3, Enrolling by invitation 2

Follow Neuromuscular Diseases: new trials by email Literature Review of Neuromuscular Diseases trials Research Report on Neuromuscular Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes
Phase 2WithdrawnStanford University2099-01-012024-11-22
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN
Tetramethylpyrazine nitrone (TBN) tablet / Placebo - Healthy
Phase 1Not yet recruitingGuangzhou Magpie Pharmaceuticals Co., Ltd.162028-09-012026-09-11
Evaluation of Donor-Derived B Cell Infusions in Patients With Amyotrophic Lateral Sclerosis (ALS)
B cell infusion - ALS - Amyotrophic Lateral Sclerosis
Phase 1Not yet recruitingMark Poznansky102027-09-012026-09-24
Feasibility and Preliminary Effects of an Asynchronous Microlearning Intervention on Fibromyalgia Knowledge Among Primary Health Care Workers
Written Educational Material on Fibromyalgia, Asynchronous Microlearning Intervention on Fibromyalgia - Fibromyalgia, Fibromyalgia (FM)
Not applicableNot yet recruitingInstituto Neurociencia Del Dolor682027-06-012026-10-13
Hypersound Treatment for Chronic Neuropathic and Radicular Pain
Hypersound RF-PNS system, Sham Hypersound - Chronic Neuropathic Pain, Radiculopathy
Not applicableNot yet recruitingHypersound Medical Inc712027-06-012026-09-21
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29
Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain
AFA-281 - Lumbosacral Radiculopathy
Phase 2Not yet recruitingAfasci Inc4082027-04-012025-06-26
Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
Myasthenia Gravis Generalized
Not yet recruitingBioSensics252027-03-152026-10-13
Graded Motor Imagery in Carpal Tunnel Syndrome
Graded Motor Imagery (GMI), Progressive Neurodynamic Exercise, Nighttime Resting Splint - Carpal Tunnel Syndrome (CTS)
Not applicableNot yet recruitingArtvin Coruh University462027-03-012026-09-02
Safety Study of XT-150 in Participants With ALS
XT-150 - Amyotrophic Lateral Sclerosis (ALS)
Phase 1Not yet recruitingXalud Therapeutics, Inc.82027-03-012026-07-29
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
TEAM-LEADS - Lupus, Dermatomyositis, Juvenile
Not applicableNot yet recruitingDuke University252027-02-012026-05-27
Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2
SP-102, Placebo, Dexamethasone Sodium Phosphate 10 MG/ML - Lumbosacral Radicular Pain
Phase 3Not yet recruitingSemnur Pharmaceuticals, Inc.7552027-02-012026-09-09
Effects of Hydrogen-rich Water Consumption on Transient Fatigue During an Official Football Match.
Hydrogen-Rich Water (HRW), Placebo Water - Exercise-Induced Fatigue, Football Performance
Not applicableNot yet recruitingPalacky University302027-01-202026-10-08
Randomized Evaluation of Lumbar Injection Effectiveness and Function
Triojection® System, Selective Nerve Root Block (SNRB) - Lumbar Radiculopathy, Lumbar Disc Herniation
Not applicableNot yet recruitingSpinaFX Medical Inc.3002027-01-152026-10-07
Comparison of Efficacy of Caudal Versus Transforaminal Epidural Steroid Injections in Unilateral S1 Nerve Root Pain: A Randomized Controlled Trial
Caudal Epidural Steroid Injection (CEI), Transforaminal Epidural Steroid Injection (TFI) - Unilateral S1 Nerve Root Pain
Not applicableNot yet recruitingUniversity of Health Sciences Lahore1202027-01-052026-10-16
BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)
Active BreEStim Treatment, Sham BreEStim Treatment, The TENS Treatment - Pain Management
Not applicableNot yet recruitingThe University of Texas Health Science Center, Houston662027-01-042026-10-14
AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial
AI Combined (mobility and resistance training), AI mobility - Fibromyalgia, Fibromyalgia (FM)
Not applicableNot yet recruitingInstituto Neurociencia Del Dolor662027-01-042026-07-01
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor)
Phase 2Not yet recruitingGirish Dhall, MD232027-01-012026-08-04
Treatment of Fibromyalgia and PTSD With Live and Inactive Vagus Nerve Stimulation With PEPC
tAN plus PEPC, sham plus PEPC - Fibromyalgia (FM), Posttraumatic Stress Disorder (PTSD)
Not applicableNot yet recruitingVA Office of Research and Development1802027-01-012026-09-29

Showing 20 of 9905. Sign in to see all of them.

Narrower conditions

Fibromyalgia (1230)  ·  Neuralgia (979)  ·  Amyotrophic Lateral Sclerosis (972)  ·  Pain (689)  ·  Carpal Tunnel Syndrome (579)  ·  Diabetic Neuropathies (522)  ·  Muscular Dystrophy, Duchenne (478)  ·  Peripheral Nervous System Diseases (476)  ·  Chronic Pain (446)  ·  Radiculopathy (431)  ·  Myasthenia Gravis (319)  ·  Muscular Atrophy, Spinal (277)  ·  Poliomyelitis (262)  ·  Fatigue Syndrome, Chronic (260)

Broader conditions

Nervous System Diseases (9816)  ·  Peripheral Nervous System Diseases (4302)  ·  Pathological Conditions, Signs and Symptoms (3684)  ·  Musculoskeletal Diseases (3477)  ·  Muscular Diseases (3056)  ·  Signs and Symptoms (2983)  ·  Neurologic Manifestations (2791)  ·  Neurodegenerative Diseases (2506)  ·  Central Nervous System Diseases (2049)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1880)  ·  Genetic Diseases, Inborn (1783)  ·  Pain (1727)  ·  Nutritional and Metabolic Diseases (1725)  ·  Spinal Cord Diseases (1713)

Interventions

Pregabalin (159)  ·  Exercise (138)  ·  Lidocaine (84)  ·  Sodium Chloride (64)  ·  Surveys and Questionnaires (63)  ·  Saline Solution (60)  ·  Acupuncture Therapy (59)  ·  Blood Specimen Collection (58)  ·  Duloxetine Hydrochloride (58)  ·  Physical Therapy Modalities (58)  ·  Transcranial Direct Current Stimulation (54)  ·  Transcutaneous Electric Nerve Stimulation (49)  ·  Control Groups (48)  ·  Gabapentin (48)  ·  Transcranial Magnetic Stimulation (44)

Sponsors

Riphah International University (124)  ·  Cairo University (98)  ·  Assistance Publique - Hôpitaux de Paris (94)  ·  GlaxoSmithKline (71)  ·  Assiut University (61)  ·  Copenhagen University Hospital, Rigshospitalet (59)  ·  Massachusetts General Hospital (59)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (58)  ·  Pfizer (56)  ·  Novartis Pharmaceuticals (55)  ·  Mayo Clinic (53)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (52)  ·  National Cancer Institute (NCI) (50)  ·  Biogen (49)  ·  Johns Hopkins University (49)

Countries

United States (3358)  ·  France (950)  ·  Turkey (Türkiye) (746)  ·  United Kingdom (649)  ·  Spain (648)  ·  Canada (642)  ·  Italy (613)  ·  Germany (598)  ·  China (564)  ·  Netherlands (383)  ·  Belgium (362)  ·  Denmark (334)  ·  Egypt (282)  ·  Poland (275)  ·  Australia (255)

Top investigators

Yung-Tsan Wu, MD (15)  ·  Amal Fawzy, Ph.d (14)  ·  Brigitte C Widemann, M.D. (13)

Results publications

PMID 34854473, PMID 27611736, PMID 31420846, PMID 20461783, PMID 34383289, PMID 41766528, PMID 23024624, PMID 25794202, PMID 37148485, PMID 41224659, PMID 42578463, PMID 19465371, PMID 20961685, PMID 24405257, PMID 26694975, PMID 27448285, PMID 28778254, PMID 30084288, PMID 30206821, PMID 30521533, PMID 30936738, PMID 31284771, PMID 31802967, PMID 38059274, PMID 10846153, PMID 11884154, PMID 12151246, PMID 12723749, PMID 12918862, PMID 12973155, PMID 15784928, PMID 16448572, PMID 16848101, PMID 16862046, PMID 16967609, PMID 17413924, PMID 18003941, PMID 18209131, PMID 18316238, PMID 18482862, PMID 18495734, PMID 18809959, PMID 1894754, PMID 19119380, PMID 19119381, PMID 19251067, PMID 19345936, PMID 19487826, PMID 19782873, PMID 20052961

NIH funding

2023 (61), 2025 (46), 2017 (33), 2018 (32), 2019 (31), 2016 (28), 2015 (27), 2014 (25), 2009 (15), 2008 (10), 2005 (6), U10CA180886 (5), U54NS078059 (5), 2004 (4), U54NS065712 (4)